PharmaNet, a Princeton, N.J., clinical drug development company once under U.S. Senate investigation for its treatment of human test subjects, now faces an avalanche of shareholder litigation. A putative class-action suit in federal court in Newark, N.J., alleges the company and its top executives made false and misleading statements to investors, engaged in improper business practices and tried to cover them up.
November 28, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
PharmaNet, a Princeton, N.J., clinical drug development company once under U.S. Senate investigation for its treatment of human test subjects, now faces an avalanche of shareholder litigation.
A putative class-action suit in federal court in Newark alleges the company and its top executives made false and misleading statements to investors, engaged in improper business practices and tried to cover them up.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
